Latest round: IPO. Stephen Dilly is the former President and Chief Executive Officer of Sierra Oncology.
Stephen Dilly is the former President and Chief Executive Officer of Sierra Oncology. During his tenure, Sierra Oncology successfully completed a Phase 3 trial and was acquired by GSK for $1.9 billion. He is currently CEO of Codexis Inc. and previously served as CEO of Aimmune Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide